These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28810742)

  • 1. Determination of Rate-Limiting Factor for Formation of Beta-Catenin Destruction Complexes Using Absolute Protein Quantification.
    Kitazawa M; Hatta T; Ogawa K; Fukuda E; Goshima N; Natsume T
    J Proteome Res; 2017 Oct; 16(10):3576-3584. PubMed ID: 28810742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Transcription Factor SP1 by the β-Catenin Destruction Complex Modulates Wnt Response.
    Mir R; Sharma A; Pradhan SJ; Galande S
    Mol Cell Biol; 2018 Nov; 38(22):. PubMed ID: 30181396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thr160 of Axin1 is critical for the formation and function of the β-catenin destruction complex.
    Koyama-Nasu R; Hayashi T; Nasu-Nishimura Y; Akiyama T; Yamanaka R
    Biochem Biophys Res Commun; 2015 Apr; 459(3):411-5. PubMed ID: 25735981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular assembly of the beta-catenin destruction complex and the effect of Wnt signaling on its localization, molecular size, and activity in vivo.
    Schaefer KN; Bonello TT; Zhang S; Williams CE; Roberts DM; McKay DJ; Peifer M
    PLoS Genet; 2018 Apr; 14(4):e1007339. PubMed ID: 29641560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APC mutations disrupt β-catenin destruction complex condensates organized by Axin phase separation.
    Zhang D; Ni QQ; Wang SY; He WF; Hong ZX; Liu HY; Chen XH; Chen LJ; Han FY; Zhang LJ; Li XM; Ding YQ; Jiao HL; Ye YP
    Cell Mol Life Sci; 2024 Jan; 81(1):57. PubMed ID: 38279052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase separation of Axin organizes the β-catenin destruction complex.
    Nong J; Kang K; Shi Q; Zhu X; Tao Q; Chen YG
    J Cell Biol; 2021 Apr; 220(4):. PubMed ID: 33651074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ICAT as an APC Inhibitor, Revealing Wnt-Dependent Inhibition of APC-Axin Interaction.
    Ji L; Lu B; Wang Z; Yang Z; Reece-Hoyes J; Russ C; Xu W; Cong F
    Mol Cell; 2018 Oct; 72(1):37-47.e4. PubMed ID: 30197296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation.
    Ranes M; Zaleska M; Sakalas S; Knight R; Guettler S
    Mol Cell; 2021 Aug; 81(16):3246-3261.e11. PubMed ID: 34352208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APC controls Wnt-induced β-catenin destruction complex recruitment in human colonocytes.
    Parker TW; Neufeld KL
    Sci Rep; 2020 Feb; 10(1):2957. PubMed ID: 32076059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15.
    Huang X; Langelotz C; Hetfeld-Pechoc BK; Schwenk W; Dubiel W
    J Mol Biol; 2009 Aug; 391(4):691-702. PubMed ID: 19576224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent Axin and GSK-3 paralogs in the beta-catenin destruction complexes of tapeworms.
    Montagne J; Preza M; Castillo E; Brehm K; Koziol U
    Dev Genes Evol; 2019 Jul; 229(4):89-102. PubMed ID: 31041506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible modification of adenomatous polyposis coli (APC) with K63-linked polyubiquitin regulates the assembly and activity of the β-catenin destruction complex.
    Tran H; Polakis P
    J Biol Chem; 2012 Aug; 287(34):28552-63. PubMed ID: 22761442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
    Schmitz Y; Rateitschak K; Wolkenhauer O
    Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
    Schneikert J; Ruppert JG; Behrens J; Wenzel EM
    PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destruction complex dynamics: Wnt/β-catenin signaling alters Axin-GSK3β interactions
    Lybrand DB; Naiman M; Laumann JM; Boardman M; Petshow S; Hansen K; Scott G; Wehrli M
    Development; 2019 Jul; 146(13):. PubMed ID: 31189665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling.
    Dominguez-Brauer C; Khatun R; Elia AJ; Thu KL; Ramachandran P; Baniasadi SP; Hao Z; Jones LD; Haight J; Sheng Y; Mak TW
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1148-E1157. PubMed ID: 28137882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The β-catenin destruction complex.
    Stamos JL; Weis WI
    Cold Spring Harb Perspect Biol; 2013 Jan; 5(1):a007898. PubMed ID: 23169527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstituting regulation of the canonical Wnt pathway by engineering a minimal β-catenin destruction machine.
    Pronobis MI; Deuitch N; Posham V; Mimori-Kiyosue Y; Peifer M
    Mol Biol Cell; 2017 Jan; 28(1):41-53. PubMed ID: 27852897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
    Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
    Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphisms in APC, DVL2, and AXIN1 Are Associated with Susceptibility, Advanced TNM Stage or Tumor Location in Colorectal Cancer.
    Rosales-Reynoso MA; Saucedo-Sariñana AM; Contreras-Díaz KB; Márquez-González RM; Barros-Núñez P; Pineda-Razo TD; Marin-Contreras ME; Durán-Anguiano Ó; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
    Tohoku J Exp Med; 2019 Nov; 249(3):173-183. PubMed ID: 31723073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.